AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

METFORMIN HYDROCHLORIDE 500 Mg ;

11 registrations across 1 African market— 11 active

Markets with METFORMIN HYDROCHLORIDE 500 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Alexodiab 500 mg
Tablets
🇪🇬EgyptAlexandria Co. For Pharmaceuticals and Chemical Industriesactive
Metformin Tablets (BP 2019)
Film Coated Tablets
🇪🇬EgyptSouth Egypt Drug Industries Co (SEDICO)active
Glucophage XR
Prolonged release tablets
🇪🇬EgyptMerck Limited - Egyptactive
Kelvamet 500 mg
MODIFIED RELEASE TABLETS
🇪🇬EgyptBio Med For Pharmaceutical Industries (BIOMED)active
Megloform
Oral Solution
🇪🇬EgyptHochster pharmaceutical industriesactive
Metformin-Evapharma 500 mg
Extended Release Tablet
🇪🇬EgyptEVAPHARMA for Pharmaceutical Industries ( EVAPHARMA)active
Glucophage XR
Prolonged release tablets
🇪🇬EgyptMerck Limited - Egyptactive
Kelvamet 500 mg
MODIFIED RELEASE TABLETS
🇪🇬EgyptBio Med For Pharmaceutical Industries (BIOMED)active
Alexodiab 500 mg
Tablets
🇪🇬EgyptAlexandria Co. For Pharmaceuticals and Chemical Industriesactive
Metformin tablets 500 mg B.P 2022
Tablets
🇪🇬EgyptEl-Nasr for Pharmaceutical Chemicalsactive
Metformin Tablets (BP 2019)
Film Coated Tablets
🇪🇬EgyptSouth Egypt Drug Industries Co (SEDICO)active

METFORMIN HYDROCHLORIDE 500 Mg ; in Africa — Regulatory Overview

METFORMIN HYDROCHLORIDE 500 Mg ; is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.